SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer

Jin Li, Shukui Qin, Hongming Pan et al.|Cancer Immunology Immunotherapy|2024

Cited by 15